Related Experiment Video
Updated: Aug 12, 2026

Genetic and Biochemical Approaches for In Vivo and In Vitro Assessment of Protein Oligomerization: The Ryanodine Receptor Case Study
Published on: July 27, 2016
Old dog, new trick: Charybdotoxin as a novel ryanodine receptor blocker
Zsuzsanna Édua Magyar1, Judit Hevesi2,3, Frigyes Mészáros4
1Department of Physiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Abstract:
Ryanodine receptors (RyRs) are Ca2 +-release channels of the sarcoplasmic reticulum. Because uncontrolled Ca2 +-release underlies several muscle and cardiac disorders, pharmacological inhibition of RyRs represents an attractive therapeutic strategy. Natural peptide toxins have provided valuable molecular templates for inhibitor design, with calcins being a particularly promising group. Calcins bind RyRs with high specificity, but, instead of producing the desired full channel block, they stabilize subconductance states that promote Ca2 + leak. Given the mechanistic similarity between calcins' action and the well-known charybdotoxin (ChTX)-mediated K+ channel blockade, we examined whether ChTX showed functional cross-reactivity with RyR channels. Single-channel recordings were performed on skeletal muscle RyRs reconstituted into lipid bilayers. ChTX induced long-lasting (>0.5 s) closed events (LLCEs) in a voltage-dependent manner with an apparent Kd of 85 nm at +60 mV. Under these conditions, channels spent ∼10 s min-1 in the LLCE state. Notably, isosteric substitution of K27, which is essential for K+ channel block, retained RyR inhibition, indicating a pore interaction mechanistically distinct from that described in K+ channels. Cardiac RyRs were similarly affected by the K27N variant. Guided by in silico docking to the RyR cryo-electron microscopy structure, we mapped the ChTX-RyR interaction surface using five additional ChTX variants, focusing on basic residues. We found that the R25Q and R34Q substitutions abolished LLCE formation, whereas others had no effect or enhanced channel block. These results describe a novel ChTX-RyR interaction mode functionally convergent with calcin peptides, and they also identify K27N ChTX as a selective RyR inhibitor and a promising scaffold for future drug design. KEY POINTS: Charybdotoxin (ChTX) blocks ryanodine receptor (RyR) single channel currents in bilayer recordings. Amino acid residues R25 and R34 are essential for the block. K27, which is important for K+ channel block, is irrelevant in RyR block; thereby, the K27N ChTX variant represents a RyR-selective blocker. ChTX shares a common binding site with calcin peptides in the channel vestibule, outside the gate.
Related Concept Videos
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Depolarizing Blockers: Mechanism of Action
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...

